-
Mashup Score: 2
A recent study from researchers in Drexel University’s College of Nursing and Health Professions and Dornsife School of Public Health aimed to understand the challenges and supports affecting individuals with GI cancer and their caregivers when it comes to maintaining a healthy diet and avoiding malnutrition.
Source: drexel.eduCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Could Eating Turkey Ease Colitis? - 4 month(s) ago
Thanksgiving is often a time for thinking about your belly. For those with an inflammatory bowel diseases like ulcerative colitis, feasting can be associated with stress. New research in mice suggests that certain foods – especially those high in tryptophan, like turkey, pork, nuts and seeds – could reduce the risk of a colitis flare. The findings point to a noninvasive method of improving…
Source: www.jefferson.eduCategories: General Medicine News, Onc News and JournalsTweet-
#ResearchWednesday: A study in mice led by SKCC member Dr. Sangwon Kim & published in @NatureComms found that extra tryptophan in turkey and other foods could reduce the risk of future colitis flares. Read more: https://t.co/Y35LmpCpa4 @ResearchAtJeff https://t.co/nTxo6frotD
-
-
Mashup Score: 1The association of the G8 questionnaire with treatment side effects and unscheduled care among older adults with breast cancer: A retrospective cohort study - 10 month(s) ago
Author links open overlay panel, , , , , , ,
Source: www.sciencedirect.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ResearchWednesday: New research from the Sidney Kimmel Cancer Center evaluates the G8 questionnaire among older adults with cancer. Read more: https://t.co/nbEz55Jktf @andrewchap361 @KristineSwartz3 @DrLouisCappelli @anamarialopezmd #GeriOnc https://t.co/zLrQ7Tr45T
-
-
Mashup Score: 0Physician Perceptions on Cancer Screening for LGBTQ+ Patients - 10 month(s) ago
The LGBTQ+ community experiences cancer disparities due to increased risk factors and lower screening rates, attributable to health literacy gaps and systemic barriers. We sought to understand the experiences, perceptions, and knowledge base of healthcare providers regarding cancer screening for LGBTQ+ patients. A 20-item IRB-approved survey was distributed to physicians through professional…
Source: MDPICategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
To tackle #HealthDisparities affecting LGBTQ+ patients, SKCC researchers assessed medical providers' experience & perceptions regarding cancer screenings in the community & discuss areas for improvement in care delivery & future research #ResearchWednesday https://t.co/Cvad4OXirb https://t.co/4VvIYUvo9J
-
-
Mashup Score: 0
Background The phase 3 CheckMate 649 established superior overall survival of nivolumab in combination with chemotherapy (NIVO + chemo) compared with chemotherapy (chemo) alone as a first-line treatment for patients with Her2-negative advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJC/EAC). This post hoc trial analysis aimed to evaluate the benefit…
Source: SpringerLinkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ResearchWednesday: In a post hoc analysis @DanielLinMD & colleagues found nivolumab + chemo was associated with a gain in quality-adjusted survival compared w chemo alone in advanced esophageal adenocarcinoma & gastric & gastroesophageal junction cancers: https://t.co/NJqu59wNRm
-
-
Mashup Score: 0Jefferson Investigates: Discrimination’s Impact on Recovery, Cannabis for Chronic Pain, and Cancer’s Blood Supply - 11 month(s) ago
Does discrimination slow recovery from brain trauma, can patients with long-term pain use cannabis to reduce opioids use, will blocking blood flow to cancer slow its growth?
Source: The NexusCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ResearchWednesday: A new pathway to starve tumors? Dr. Renato Iozzo's lab discovered that boosting endorepellin levels inhibited the angiogenesis pathway and decreased tumor volume in mice. Read more @ResearchAtJeff ➡️ https://t.co/byJfC4rdVa
-
-
Mashup Score: 0
The results may help guide the decision between a partial and radical nephrectomy in patients with stage T1b to T2 renal cell carcinoma.
Source: Urology TimesCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Specific comorbidities may predict complications after partial nephrectomy in patients with renal cell carcinoma, according to research @yashah01 presented at #AUA23: https://t.co/khg78dQlnR #ResearchWednesday @JEFFUrology
-
-
Mashup Score: 1Lack of Provider Training Creates Healthcare Barriers for Individuals with Intellectual or Developmental Disabilities | Jefferson Health - 1 year(s) ago
Individuals with autism and intellectual or developmental disabilities (IDD) face damaging consequences due to numerous barriers to care across healthcare settings, including lack of training in providers. A study led by Wendy J. Ross, MD, Director of the Jefferson Center for Autism and Neurodiversity, and Avnish Bhatia, MD, Assistant Professor of Medical Oncology and Director of Clinical…
Source: www.jeffersonhealth.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ResearchWednesday: Last week at #AACR23, Drs. Wendy Ross & @AvnishBhatiaMD presented insights into oncology care providers' experiences caring for patients with Intellectual or Developmental Disabilities. Read more: https://t.co/Ycf5PqzlhW https://t.co/WpSvanJ1Bd
-
-
Mashup Score: 4SKCC Researchers Discover and Target an Unexpected Achilles Heel in Triple-negative Breast Cancer | Jefferson Health - 1 year(s) ago
Researchers at Jefferson Health’s Sidney Kimmel Cancer Center (SKCC) have developed a novel therapeutic strategy that could revolutionize Triple-negative breast cancer (TNBC) treatment – and are challenging scientific beliefs in the process.
Source: www.jeffersonhealth.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New @ResearchAtJeff published in @CD_AACR: SKCC investigators identified an unexpected vulnerability of p53-inactivated triple-negative #BreastCancer & with @TheWistar colleagues, designed and tested an entirely new type of compound. https://t.co/ESQ78n8G3j #ResearchWednesday https://t.co/W2aS6lcQZI
-
-
Mashup Score: 0Neuronal Molecule Makes Prostate Cancer More Aggressive - 1 year(s) ago
PHILADELPHIA – Prostate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers have discovered key molecular players that drive prostate cancer to progress into a highly aggressive form of the disease called neuroendocrine prostate cancer that currently has no effective treatment. The finding uncovers new avenues to explore for…
Source: www.jefferson.eduCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Dr. @LLanguino & team have discovered key molecules that drive a highly aggressive form of #ProstateCancer called neuroendocrine tumors. The finding, published in @SciReports, uncovers a novel therapeutic avenue. @ResearchAtJeff #ResearchWednesday More: https://t.co/XLkVZOhNy1 https://t.co/FlOSzCDHHo
-
#ResearchWednesday: A study from @drexelpubhealth professor & SKCC member Dr. Ann Klassen & colleagues highlighted barriers to maintaining a healthy diet for GI cancer patients & their caregivers, which was published in Cancer Control @SageJournals ➡️ https://t.co/bRmdrVMn7Z